Ignite Creation Date:
2025-12-24 @ 1:18 PM
Ignite Modification Date:
2026-01-20 @ 4:36 PM
Study NCT ID:
NCT02397395
Status:
WITHDRAWN
Last Update Posted:
2015-07-17
First Post:
2015-03-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.
Sponsor:
Janssen R&D Ireland
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR106396
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None